Madi Paradkar
Overview
Madi Paradkar focuses her practice on high-stakes patent litigation across the medical device, pharmaceutical, and biotechnology industries, handling matters in federal district courts, the U.S. International Trade Commission (ITC), inter partes reviews before the Patent Trial and Appeal Board (PTAB), and U.S. Federal Circuit appeals. Drawing on her scientific foundation in biology and competitive Division I athletics background, she brings analytical rigor and strategic thinking to complex intellectual property challenges. Madi's experience spans all phases of patent litigation, including discovery, claim construction, trial preparation, and U.S. Federal Circuit briefings.
Career & Education
- University of Illinois Chicago School of Law, J.D., magna cum laude, 2023
- La Salle University, B.S., biology, 2020
- Illinois
- U.S. Court of Appeals for the Federal Circuit
Madi's Insights
Client Alert | 5 min read | 07.01.26
What U.S. Patent Holders Need to Know About Inequitable Conduct Right Now
If a court finds that a patent applicant intentionally misrepresented or withheld material information from the USPTO with the intent to deceive, the consequences are severe, leading to unenforceability of the entire patent (and likely any later patents claiming priority to the unenforceable patent).
Madi's Insights
Client Alert | 5 min read | 07.01.26
What U.S. Patent Holders Need to Know About Inequitable Conduct Right Now
If a court finds that a patent applicant intentionally misrepresented or withheld material information from the USPTO with the intent to deceive, the consequences are severe, leading to unenforceability of the entire patent (and likely any later patents claiming priority to the unenforceable patent).
